{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:26:50Z","timestamp":1791163610070,"version":"4.1.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jocn.2008.08.033","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T08:59:00Z","timestamp":1239181140000},"page":"733-741","source":"Crossref","is-referenced-by-count":185,"title":["Guillain-Barr\u00e9 syndrome: An update"],"prefix":"10.1016","volume":"16","author":[{"given":"Steve","family":"Vucic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cornblath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2008.08.033_bib1","first-page":"1462","article-title":"Sur un syndrome de radiculonevrite avec hyperalbuminose du liquide cephalo-rachidien sans reaction cellilaire. Remarques sur les caracteres cliniques et graphiques des reflexes tendineux","author":"Guillain","year":"1916","journal-title":"Bull Soc Med Hop Paris"},{"key":"10.1016\/j.jocn.2008.08.033_bib2","first-page":"133","article-title":"Acute idiopathic polyneuritis. An electron microscope study","volume":"26","author":"Prineas","year":"1972","journal-title":"Lab Invest"},{"key":"10.1016\/j.jocn.2008.08.033_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0140-6736(91)90606-P","article-title":"Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China","volume":"338","author":"McKhann","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2008.08.033_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of the motor-sensory axonal Guillain-Barr\u00e9 syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Fisher","year":"1956","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.jocn.2008.08.033_bib8","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain-Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocn.2008.08.033_bib9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0404.2004.00272.x","article-title":"Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996","volume":"110","author":"Bogliun","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2008.08.033_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00007844","article-title":"Distinct pattern of age-specific incidence of Guillain-Barr\u00e9 syndrome in Harbin, China","volume":"249","author":"Cheng","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib11","doi-asserted-by":"crossref","unstructured":"Guillain-Barr\u00e9 Syndrome Study Group. Guillain-Barr\u00e9 syndrome: an Italian multicentre case-control study. Guillain-Barr\u00e9 Syndrome Study Group. Neurol Sci 2000;21:229\u2013234.","DOI":"10.1007\/s100720070081"},{"key":"10.1016\/j.jocn.2008.08.033_bib12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barr\u00e9 syndrome: epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.jocn.2008.08.033_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib14","unstructured":"Centers for Disease Control and Prevention. Guillain-Barr\u00e9 syndrome \u2013 United States. MMWR Morb Mortal Wkly Rep 1976;25:401\u20132."},{"key":"10.1016\/j.jocn.2008.08.033_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain-Barr\u00e9 Syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/oxfordjournals.aje.a113810","article-title":"Guillain-Barr\u00e9 syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977","volume":"119","author":"Breman","year":"1984","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib17","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.243.24.2490","article-title":"Guillain-Barr\u00e9 Syndrome in recipients of A\/New Jersey influenza vaccine","volume":"243","author":"Marks","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2008.08.033_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain-Barr\u00e9 syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.248.6.698","article-title":"Guillain-Barr\u00e9 syndrome in the United States, 1979\u20131980 and 1980\u20131981: lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2008.08.033_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/oxfordjournals.aje.a115974","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccination in the US Army, 1980\u20131988","volume":"133","author":"Roscelli","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib21","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 syndrome following influenza vaccination","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2008.08.033_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain-Barr\u00e9 syndrome in the United Kingdom, 1992 to 2000","volume":"166","author":"Hughes","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain-Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib24","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib25","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2007.03.053","article-title":"Guillain-Barr\u00e9 syndrome after vaccination in United States a report from the CDC\/FDA Vaccine Adverse Event Reporting System","volume":"25","author":"Souayah","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jocn.2008.08.033_bib26","unstructured":"Centers for Disease Control and Prevention (CDC). Guillain-Barr\u00e9 syndrome among recipients of Menactra meningococcal conjugate vaccine \u2013 United States, June-July 2005. MMWR Morb Mortal Wkly Rep 2005;54:1023\u20131025."},{"key":"10.1016\/j.jocn.2008.08.033_bib27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bjps.2005.10.017","article-title":"Guillain-Barr\u00e9 syndrome following facial bone fracture","volume":"59","author":"Lin","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jocn.2008.08.033_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/pgmj.63.740.479","article-title":"Guillain-Barr\u00e9 syndrome following acute head trauma","volume":"63","author":"Duncan","year":"1987","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jocn.2008.08.033_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1590\/S0004-282X1997000200022","article-title":"Guillain-Barr\u00e9 syndrome and head trauma. Case report","volume":"55","author":"De Freitas","year":"1997","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.jocn.2008.08.033_bib30","first-page":"913","article-title":"Guillain-Barr\u00e9 syndrome after mandibular surgery: report of case","volume":"30","author":"Shuert","year":"1972","journal-title":"J Oral Surg"},{"key":"10.1016\/j.jocn.2008.08.033_bib31","first-page":"549","article-title":"Cardiorespiratory arrest as a complication of Guillain-Barr\u00e9 syndrome in a postsurgical patient","volume":"36","author":"Hickory","year":"1978","journal-title":"J Oral Surg"},{"key":"10.1016\/j.jocn.2008.08.033_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0002-8703(87)90736-8","article-title":"Guillain-Barr\u00e9 syndrome following coronary artery bypass surgery","volume":"113","author":"Renlund","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.jocn.2008.08.033_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0167-5273(92)90248-2","article-title":"Guillain-Barr\u00e9 syndrome following cardiopulmonary bypass","volume":"35","author":"Hogan","year":"1992","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib34","first-page":"817","article-title":"Guillain-Barr\u00e9 syndrome after heart transplantation","volume":"11","author":"Baldwin","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jocn.2008.08.033_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01376517-199210000-00004","article-title":"An unusual nursing challenge: Guillain-Barr\u00e9 syndrome following cranial surgery","volume":"24","author":"Parobeck","year":"1992","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.jocn.2008.08.033_bib36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1445-1433.2004.03198.x","article-title":"Guillain-Barr\u00e9 syndrome following oesophagectomy","volume":"74","author":"Chouillard","year":"2004","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jocn.2008.08.033_bib37","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0028-3770(05)83637-9","article-title":"Guillain-Barr\u00e9 syndrome secondary to cranial surgery: direct or fortuitous relationship?","volume":"51","author":"Foubert-Samier","year":"2005","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.jocn.2008.08.033_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3171\/jns.1992.77.5.0694","article-title":"Cell-mediated immunity in severely head-injured patients: the role of suppressor lymphocytes and serum factors","volume":"77","author":"Quattrocchi","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2008.08.033_bib39","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006842-199307000-00004","article-title":"Stress and immunity in humans: a meta-analytic review","volume":"55","author":"Herbert","year":"1993","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib40","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.298.14.1685","article-title":"Psychological stress and disease","volume":"298","author":"Cohen","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2008.08.033_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/08977150260139129","article-title":"Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury","volume":"19","author":"Hayes","year":"2002","journal-title":"J Neurotrauma"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2008.08.033_bib42","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1007\/s10072-006-0548-4","article-title":"Guillain-Barr\u00e9 syndrome","volume":"27","author":"Cosi","year":"2006","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib43","first-page":"249","article-title":"Recurrent Guillain-Barr\u00e9 Syndrome: a clinical, electrophysiological and morphological study","volume":"43","author":"Taly","year":"1995","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jocn.2008.08.033_bib44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/jnnp.2004.051136","article-title":"Recovery patterns and long term prognosis for axonal Guillain-Barr\u00e9 syndrome","volume":"76","author":"Hiraga","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2008.08.033_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-0404.2001.103005267.x","article-title":"Axonal Guillain-Barr\u00e9 syndrome: a critical review","volume":"103","author":"Chowdhury","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2008.08.033_bib46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.54.4.1000","article-title":"Chronic ophthalmoplegia with anti-GQ1b antibody","volume":"54","author":"Reddel","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mus.20835","article-title":"Clinical and immunological spectrum of the Miller Fisher syndrome","volume":"36","author":"Lo","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib48","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.56.8.1104","article-title":"Clinical features and prognosis of Miller Fisher syndrome","volume":"56","author":"Mori","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archneur.1980.00500550086016","article-title":"The not-so-benign Miller Fisher syndrome: a variant of the Guillain-Barr\u00e9 syndrome","volume":"37","author":"Blau","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0387-7604(01)00409-0","article-title":"Miller Fisher syndrome with transient coma: comparison with Bickerstaff brainstem encephalitis","volume":"24","author":"Matsumoto","year":"2002","journal-title":"Brain Dev"},{"key":"10.1016\/j.jocn.2008.08.033_bib51","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.74.5.689","article-title":"Association of cardiomyopathy caused by autonomic nervous system impairment with the Miller Fisher syndrome","volume":"74","author":"Oomura","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2008.08.033_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/jnnp.67.2.206","article-title":"Bilateral ballism in a patient with overlapping Fisher\u2019s and Guillain-Barr\u00e9 syndromes","volume":"67","author":"Odaka","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.jocn.2008.08.033_bib53","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib54","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib55","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome","volume":"45","author":"Van der Meche","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mus.20022","article-title":"Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"29","author":"Van den Bergh","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib58","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/(SICI)1097-4598(199810)21:10<1275::AID-MUS5>3.0.CO;2-8","article-title":"Electrophysiological studies in the Guillain-Barr\u00e9 syndrome: distinguishing subtypes by published criteria","volume":"21","author":"Alam","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib59","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1002\/ana.410270706","article-title":"Electrophysiology in Guillain-Barr\u00e9 syndrome","author":"Cornblath","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mus.880120602","article-title":"Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features","volume":"12","author":"Albers","year":"1989","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib61","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ana.410090705","article-title":"Electrophysiological studies in the Guillain-Barr\u00e9 syndrome","volume":"9","author":"McLeod","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mus.880080609","article-title":"Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy","volume":"8","author":"Albers","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib63","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.clinph.2004.05.009","article-title":"Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy","volume":"115","author":"Vucic","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib64","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.58.6.913","article-title":"Early electrodiagnostic findings in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Gordon","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib65","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneur.1990.00530080065012","article-title":"Electrodiagnostic abnormalities in 113 consecutive patients with Guillain-Barr\u00e9 syndrome","volume":"47","author":"Ropper","year":"1990","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","article-title":"The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis","volume":"48","author":"Asbury","year":"1969","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl","key":"10.1016\/j.jocn.2008.08.033_bib67","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410090704","article-title":"Pathology of the Guillain-Barr\u00e9 syndrome","volume":"9","author":"Prineas","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib68","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jneuroim.2006.12.002","article-title":"Reduced circulating CD4+CD25+ cell populations in Guillain-Barr\u00e9 syndrome","volume":"183","author":"Pritchard","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2008.08.033_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02284784","article-title":"Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barr\u00e9 syndrome","volume":"25","author":"Griffin","year":"1996","journal-title":"J Neurocytol"},{"key":"10.1016\/j.jocn.2008.08.033_bib71","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mus.10488","article-title":"The refractory period of transmission is impaired in axonal Guillain-Barr\u00e9 syndrome","volume":"28","author":"Kuwabara","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib72","first-page":"121","article-title":"Immune mechanisms in demyelinating polyradiculoneuropathies","author":"Hughes","year":"2001"},{"key":"10.1016\/j.jocn.2008.08.033_bib73","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(01)00580-9","article-title":"Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barr\u00e9 syndrome","volume":"190","author":"Press","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib75","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain-Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib76","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ana.410380516","article-title":"Anti-ganglioside GM1 antibodies in Guillain-Barr\u00e9 syndrome and their relationship to Campylobacter jejuni infection","volume":"38","author":"Rees","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib77","first-page":"111","article-title":"Antibodies to gangliosides in Guillain-Barr\u00e9 syndrome: specificity and relationship to clinical features","volume":"86","author":"Gregson","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib78","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-4598(200009)23:9<1414::AID-MUS13>3.0.CO;2-0","article-title":"Anti-GM1 antibodies can block neuronal voltage-gated sodium channels","volume":"23","author":"Weber","year":"2000","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.jocn.2008.08.033_bib79","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/ana.410370405","article-title":"Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers","volume":"37","author":"Takigawa","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib80","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mus.880160603","article-title":"Acute conduction block in vitro following exposure to antiganglioside sera","volume":"16","author":"Arasaki","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib81","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410310407","article-title":"Experimental conduction block induced by serum from a patient with anti-GM1 antibodies","volume":"31","author":"Santoro","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1748-1716.1981.tb06877.x","article-title":"Electrical properties of isolated demyelinated rat nerve fibres","volume":"113","author":"Brismar","year":"1981","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.jocn.2008.08.033_bib83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1113\/jphysiol.1979.sp012843","article-title":"A quantitative description of membrane currents in rabbit myelinated nerve","volume":"292","author":"Chiu","year":"1979","journal-title":"J Physiol (Lond)"},{"key":"10.1016\/j.jocn.2008.08.033_bib84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00374660","article-title":"Action potentials and membrane currents in the human node of Ranvier","volume":"430","author":"Schwarz","year":"1995","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jocn.2008.08.033_bib85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(00)81133-2","article-title":"From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels","volume":"26","author":"Catterall","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jocn.2008.08.033_bib86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jocn.2008.08.033_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.410330202","article-title":"Molecular dissection of the myelinated axon","volume":"33","author":"Waxman","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib88","series-title":"Ionic Channels of Excitable Membranes","author":"Hille","year":"1992"},{"key":"10.1016\/j.jocn.2008.08.033_bib89","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1388-2457(01)00595-8","article-title":"Excitability of human axons","volume":"112","author":"Burke","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib90","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.410370403","article-title":"Sodium channel blockade by antibodies: a new mechanism of neurological disease?","volume":"37","author":"Waxman","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib91","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0022-510X(94)90330-1","article-title":"Conduction slowing without conduction block of compound muscle and nerve action potentials due to sodium channel block","volume":"124","author":"Yokota","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib92","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1152\/jn.1992.67.1.236","article-title":"Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability","volume":"67","author":"Stys","year":"1992","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.jocn.2008.08.033_bib93","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/BF00375050","article-title":"The acute paralysis in Guillain-Barr\u00e9 syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid","volume":"421","author":"Brinkmeier","year":"1992","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jocn.2008.08.033_bib94","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mus.880180715","article-title":"Cerebrospinal fluid and serum from patients with inflammatory polyradiculoneuropathy have opposite effects on sodium channels","volume":"18","author":"Wurz","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib95","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/WNL.43.4.809","article-title":"Localization of GM1 and Gal(beta 1\u20133)GalNAc antigenic determinants in peripheral nerve","volume":"43","author":"Corbo","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib96","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib97","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib98","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2008.08.033_bib99","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G","article-title":"Multiple measures of axonal excitability: a new approach in clinical testing","volume":"23","author":"Kiernan","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.70.1.56","article-title":"Excitability properties of motor axons in patients with spontaneous motor unit activity","volume":"70","author":"Kiernan","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2008.08.033_bib101","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.10275","article-title":"Differences in membrane properties of axonal and demyelinating Guillain-Barr\u00e9 syndromes","volume":"52","author":"Kuwabara","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib102","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/brain\/115.5.1291","article-title":"Motor nerve inexcitability in Guillain-Barr\u00e9 syndrome. The spectrum of distal conduction block and axonal degeneration","volume":"115","author":"Triggs","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib103","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/120.12.2159","article-title":"The physiological effect of anti-GM1 antibodies on saltatory conduction and transmembrane currents in single motor axons","volume":"120","author":"Hirota","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib104","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(03)00156-5","article-title":"Effects on axonal conduction of anti-ganglioside sera and sera from patients with Guillain-Barr\u00e9 syndrome","volume":"139","author":"Dilley","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2008.08.033_bib105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barr\u00e9 syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib106","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/BF00374643","article-title":"Interleukin-2 inhibits sodium currents in human muscle cells","volume":"420","author":"Brinkmeier","year":"1992","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jocn.2008.08.033_bib107","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02224393","article-title":"Localization of the pathological process in Miller Fisher syndrome","volume":"13","author":"Barontini","year":"1992","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib108","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.47.5.492","article-title":"Neuropathological findings in Miller Fisher syndrome","volume":"47","author":"Phillips","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2008.08.033_bib109","first-page":"57","article-title":"The Miller Fisher syndrome. Review of the literature","volume":"12","author":"Berlit","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"issue":"Pt 3","key":"10.1016\/j.jocn.2008.08.033_bib110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/105.3.481","article-title":"Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study","volume":"105","author":"Al-Din","year":"1982","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib111","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archneur.1985.04060010017005","article-title":"Abscence of CNS lesion in autopsied patients with Miller-Fisher syndrome","volume":"42","author":"Ropper","year":"1985","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib112","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib113","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ana.410370218","article-title":"Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome","volume":"37","author":"Jacobs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib114","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/175.3.729","article-title":"Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barr\u00e9 or Miller Fisher syndrome","volume":"175","author":"Jacobs","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocn.2008.08.033_bib115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-5728(97)00110-0","article-title":"Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barr\u00e9 and Miller Fisher syndrome","volume":"79","author":"Jacobs","year":"1997","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.jocn.2008.08.033_bib116","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0161-6420(98)97034-8","article-title":"Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni","volume":"105","author":"Ohtsuka","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jocn.2008.08.033_bib117","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.jocn.2008.08.033_bib118","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jnnp.72.3.418","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"72","author":"Panda","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2008.08.033_bib119","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/bjo.82.8.916","article-title":"Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause","volume":"82","author":"Suzuki","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jocn.2008.08.033_bib120","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0","article-title":"Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia","volume":"22","author":"Kusunoki","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib121","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/mus.20327","article-title":"Concanavalin A inhibits pathophysiological effects of anti-ganglioside GQ1b antibodies at the mouse neuromuscular synapse","volume":"31","author":"Bullens","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2008.08.033_bib122","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","article-title":"Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal","volume":"124","author":"O\u2019Hanlon","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1212\/WNL.56.1.67","article-title":"Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome","volume":"56","author":"Buchwald","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib124","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1460-9568.1998.00053.x","article-title":"Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals","volume":"10","author":"Buchwald","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jocn.2008.08.033_bib125","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/glia.20503","article-title":"Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers","volume":"55","author":"Susuki","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jocn.2008.08.033_bib126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-005-0958-x","article-title":"Long term disability and social status change after Guillain-Barr\u00e9 syndrome","volume":"253","author":"Bersano","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(02)00158-2","article-title":"Long-term impact on work and private life after Guillain-Barr\u00e9 syndrome","volume":"201","author":"Bernsen","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/01.WNL.0000055091.96905.D0","article-title":"Guillain-Barr\u00e9 syndrome: a prospective, population-based incidence and outcome survey","volume":"60","author":"Chio","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1212\/WNL.53.3.598","article-title":"Prognostic factors of Guillain-Barr\u00e9 syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barr\u00e9 Study Group","volume":"53","author":"Visser","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib130","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1212\/01.wnl.0000237334.69665.92","article-title":"CSF neurofilament levels: a potential prognostic marker in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Petzold","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib131","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib132","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0003-9993(97)90203-3","article-title":"Rehabilitation of Guillain-Barr\u00e9 syndrome","volume":"78","author":"Meythaler","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jocn.2008.08.033_bib133","doi-asserted-by":"crossref","unstructured":"Guillain-Barr\u00e9 Syndrome Study Group. Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. Neurology 1985;35:1096\u2013104.","DOI":"10.1212\/WNL.35.8.1096"},{"key":"10.1016\/j.jocn.2008.08.033_bib134","doi-asserted-by":"crossref","unstructured":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome. Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome. Ann Neurol 1997;41:298\u2013306.","DOI":"10.1002\/ana.410410304"},{"key":"10.1016\/j.jocn.2008.08.033_bib135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet."},{"key":"10.1016\/j.jocn.2008.08.033_bib136","doi-asserted-by":"crossref","unstructured":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome. Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids. Ann Neurol 1987;22:753\u2013761.","DOI":"10.1002\/ana.410220612"},{"key":"10.1016\/j.jocn.2008.08.033_bib137","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0165-5728(88)90177-4","article-title":"Role of therapeutic plasmapheresis in the acute Guillain-Barr\u00e9 syndrome","volume":"20","author":"McKhann","year":"1988","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2008.08.033_bib138","doi-asserted-by":"crossref","unstructured":"Esperou H, Jars-Guincestre MC, Bolgert F, et al. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barr\u00e9 syndrome. French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome. Intensive Care Med 2000;26:1094\u20131100.","DOI":"10.1007\/s001340051323"},{"key":"10.1016\/j.jocn.2008.08.033_bib139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1998.tb01952.x","article-title":"Safety of plasmapheresis in the treatment of neurological disease","volume":"28","author":"Vucic","year":"1998","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.jocn.2008.08.033_bib140","unstructured":"van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group. N Engl J Med 1992;326:1123\u20131129."},{"key":"10.1016\/j.jocn.2008.08.033_bib141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","article-title":"Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr\u00e9 syndrome","volume":"46","author":"Bril","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib142","doi-asserted-by":"crossref","unstructured":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Randomised trial of plasma exchange intravenous immunoglobulin and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet 1997;349:225\u2013230.","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"10.1016\/j.jocn.2008.08.033_bib143","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000050777","article-title":"A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barr\u00e9 syndrome","volume":"46","author":"Diener","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib144","first-page":"69","article-title":"A randomized controlled trial comparing intravenous immunoglobulin and plasmapheresis in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Nomura","year":"2000","journal-title":"Neurol Therapeutics"},{"key":"10.1016\/j.jocn.2008.08.033_bib145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1542\/peds.2004-1324","article-title":"Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial","volume":"116","author":"Korinthenberg","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2008.08.033_bib146","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-510X(95)00357-8","article-title":"Sequential treatment of Guillain-Barr\u00e9 syndrome with extracorporeal elimination and intravenous immunoglobulin","volume":"137","author":"Haupt","year":"1996","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib147","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2008.08.033_bib148","doi-asserted-by":"crossref","unstructured":"Raphael JC, Chevret S, Hughes RA, et al. Plasma exchange for Guillain-Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2002:CD001798.","DOI":"10.1002\/14651858.CD001798"},{"key":"10.1016\/j.jocn.2008.08.033_bib149","doi-asserted-by":"crossref","unstructured":"Farcas P, Avnun L, Frisher S, et al. Efficacy of repeated intravenous immunoglobulin in severe unresponsive Guillain-Barr\u00e9 syndrome. Lancet 1997;350:1747.","DOI":"10.1016\/S0140-6736(97)24050-X"},{"key":"10.1016\/j.jocn.2008.08.033_bib150","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib151","first-page":"329","article-title":"Role of steroids in the treatment of Guillain-Barr\u00e9 syndrome - a controlled trial","volume":"34","author":"Bansal","year":"2004","journal-title":"Neurol India"},{"key":"10.1016\/j.jocn.2008.08.033_bib152","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2008.08.033_bib153","first-page":"128","article-title":"Double blind control trial of prednisolone in Guillain-Barr\u00e9 syndrome - a clinical study","volume":"52","author":"Shukla","year":"1988","journal-title":"Clinician India"},{"key":"10.1016\/j.jocn.2008.08.033_bib154","first-page":"22","article-title":"Do corticosteroids influence the disease course or mortality in Guillain-Barr\u00e9 syndrome?","volume":"44","author":"Singh","year":"1996","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.jocn.2008.08.033_bib155","doi-asserted-by":"crossref","unstructured":"Guillain-Barr\u00e9 Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome. Lancet 1993;341:586\u2013590.","DOI":"10.1016\/0140-6736(93)90351-G"},{"key":"10.1016\/j.jocn.2008.08.033_bib156","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2008.08.033_bib157","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barr\u00e9 syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib158","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00415-006-0163-6","article-title":"Residual fatigue is independent of antecedent events and disease severity in Guillain-Barr\u00e9 syndrome","volume":"253","author":"Garssen","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib159","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1039\/B400029C","article-title":"Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barr\u00e9 syndrome","volume":"2","author":"Andersen","year":"2004","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.jocn.2008.08.033_bib160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2005.03.031","article-title":"General mechanisms of axonal damage and its prevention","volume":"233","author":"Stys","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2008.08.033_bib161","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2008.08.033_bib162","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.20546","article-title":"Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome","volume":"58","author":"Halstead","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2008.08.033_bib163","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-510X(99)00328-7","article-title":"Immunohistochemical localization of cytokines, C5b\u20139 and ICAM-1 in peripheral nerve of Guillain-Barr\u00e9 syndrome","volume":"174","author":"Putzu","year":"2000","journal-title":"J Neurol Sci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586808005274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586808005274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T11:00:08Z","timestamp":1558263608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586808005274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0967586808005274"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2008.08.033","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}